MedTrace Logo

Sidekick vs Conventional Cannula in Lumbar Medial Branch Radiofrequency Ablation

NCT07475689 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2026-03-16

No results posted yet for this study

Summary

Lumbar facet joint-mediated chronic low back pain is a common cause of disability. Radiofrequency ablation (RFA) of the lumbar medial branches is an established interventional pain treatment. Different cannula designs may influence lesion geometry and clinical outcomes.

This prospective randomized study aims to compare the clinical outcomes of conventional cannulas and sidekick cannulas used during lumbar medial branch radiofrequency ablation. Patients with chronic lumbar facet joint pain who meet inclusion criteria will be randomly assigned to receive RFA using either a conventional cannula or a sidekick cannula technique.

The primary objective is to evaluate pain reduction following the procedure. Secondary outcomes include functional improvement and duration of pain relief during follow-up.

Conditions

  • Facet Joint Pain; Low Back Pain

Interventions

PROCEDURE

Lumbar Medial Branch Radiofrequency Ablation

Lumbar medial branch radiofrequency ablation performed for chronic lumbar facet-mediated pain. The procedure is performed under fluoroscopic guidance .

DRUG

Triamcinolone (20 g)

Triamcinolone acetonide administered after ablation as part of the post-procedural injection mixture.

DRUG

bupivacain 0.5% 2ml

Bupivacaine 0.5% administered after ablation as part of the post-procedural injection mixture.

DEVICE

conventional radiofrequency cannul

standard straight radiofrequency cannula used during lumbar medial branch radiofrequency ablation

DEVICE

sidekick radiofrecueny cannula

sidekick radiofrequeny cannula designed to preduce a larger lesion during lumbaar brach medial branch radiofrequeny ablation

Sponsors & Collaborators

  • Saglik Bilimleri Universitesi Gulhane Tip Fakultesi

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2025-08-01
Completion
2025-09-24

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07475689 on ClinicalTrials.gov